Lista de obras - Elaine Kingwell - Dominio Público Uruguay

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.

artículo científico publicado en 2016

Adherence and persistence to drug therapies for multiple sclerosis: A population-based study

artículo científico publicado en 2016

Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

artículo científico publicado en 2017

Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study

artículo científico publicado en 2020

Age Related Multiple Sclerosis Severity Score: Disability ranked by age.

artículo científico publicado en 2017

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia

artículo científico publicado en 2017

Assessment of cancer risk with β-interferon treatment for multiple sclerosis.

artículo científico publicado en 2014

Association between beta-interferon exposure and hospital events in multiple sclerosis.

artículo científico publicado en 2014

Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

artículo científico

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2012

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

artículo científico publicado en 2015

Cancer risk in multiple sclerosis: findings from British Columbia, Canada

artículo científico

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

artículo científico publicado en 2010

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

artículo científico publicado en 2014

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

artículo científico publicado en 2018

Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll

artículo científico publicado en 2017

Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians.

artículo científico publicado en 2009

Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study.

artículo científico publicado en 2018

Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study

artículo científico publicado en 2019

Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women.

artículo científico publicado en 2018

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study.

artículo científico publicado en 2017

Effects of physical comorbidities on disability progression in multiple sclerosis

artículo científico publicado en 2018

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

artículo científico publicado en 2016

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

article

Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome

artículo científico publicado en 2020

Five years before multiple sclerosis onset: Phenotyping the prodrome

artículo científico publicado en 2018

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

artículo científico publicado en 2017

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).

artículo científico publicado en 2015

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study

artículo científico publicado en 2010

Hospital admissions and MS: temporal trends and patient characteristics.

artículo científico publicado en 2012

Identifying optic neuritis and transverse myelitis using administrative data

scientific article published on 13 August 2018

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

artículo científico publicado en 2013

Infection-related health care utilization among people with and without multiple sclerosis.

artículo científico publicado en 2016

Interferon beta and long-term disability in multiple sclerosis

artículo científico publicado en 2013

Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?

artículo científico publicado en 2009

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

artículo científico publicado en 2013

Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study ⬇️

artículo científico publicado el 31 de enero de 2012

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review

artículo científico

Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort

artículo científico publicado en 2014

Mining healthcare data for markers of the multiple sclerosis prodrome

artículo científico publicado en 2018

Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment

artículo científico publicado en 2015

Persistence and adherence to the new oral disease-modifying therapies for multiple sclerosis: A population-based study

scientific article published on 09 November 2018

Physical activity, body mass index and bone mineral density-associations in a prospective population-based cohort of women and men: the Canadian Multicentre Osteoporosis Study (CaMos).

artículo científico publicado en 2011

Predicting risk of secondary progression in multiple sclerosis: A nomogram

artículo científico publicado en 2018

Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada

artículo científico

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

artículo científico publicado en 2011

The natural history of primary progressive multiple sclerosis.

artículo científico publicado en 2009

The natural history of secondary progressive multiple sclerosis

artículo científico publicado en 2010

Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.

artículo científico publicado en 2016

Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years

scientific article published on 09 July 2018

Lista de obras de Elaine Kingwell

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.

Adherence and persistence to drug therapies for multiple sclerosis: A population-based study

Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study

Age Related Multiple Sclerosis Severity Score: Disability ranked by age.

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia

Assessment of cancer risk with β-interferon treatment for multiple sclerosis.

Association between beta-interferon exposure and hospital events in multiple sclerosis.

Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

Cancer risk in multiple sclerosis: findings from British Columbia, Canada

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll

Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians.

Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study.

Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study

Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women.

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study.

Effects of physical comorbidities on disability progression in multiple sclerosis

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome

Five years before multiple sclerosis onset: Phenotyping the prodrome

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study

Hospital admissions and MS: temporal trends and patient characteristics.

Identifying optic neuritis and transverse myelitis using administrative data

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

Infection-related health care utilization among people with and without multiple sclerosis.

Interferon beta and long-term disability in multiple sclerosis

Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study ⬇️

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review

Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort

Mining healthcare data for markers of the multiple sclerosis prodrome

Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment

Persistence and adherence to the new oral disease-modifying therapies for multiple sclerosis: A population-based study

Physical activity, body mass index and bone mineral density-associations in a prospective population-based cohort of women and men: the Canadian Multicentre Osteoporosis Study (CaMos).

Predicting risk of secondary progression in multiple sclerosis: A nomogram

Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

The natural history of primary progressive multiple sclerosis.

The natural history of secondary progressive multiple sclerosis

Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.

Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years